BR112023001926A2 - Composição farmacêutica de corticosteroide intra-articular para controle da dor - Google Patents

Composição farmacêutica de corticosteroide intra-articular para controle da dor

Info

Publication number
BR112023001926A2
BR112023001926A2 BR112023001926A BR112023001926A BR112023001926A2 BR 112023001926 A2 BR112023001926 A2 BR 112023001926A2 BR 112023001926 A BR112023001926 A BR 112023001926A BR 112023001926 A BR112023001926 A BR 112023001926A BR 112023001926 A2 BR112023001926 A2 BR 112023001926A2
Authority
BR
Brazil
Prior art keywords
intra
pharmaceutical composition
articular corticosteroid
pain control
articular
Prior art date
Application number
BR112023001926A
Other languages
English (en)
Portuguese (pt)
Inventor
Shih Sheue-Fang
Oscar Brown Carl
Original Assignee
Tlc Biopharmaceuticals Inc
Taiwan Liposome Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tlc Biopharmaceuticals Inc, Taiwan Liposome Co Ltd filed Critical Tlc Biopharmaceuticals Inc
Publication of BR112023001926A2 publication Critical patent/BR112023001926A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BR112023001926A 2020-08-05 2021-08-05 Composição farmacêutica de corticosteroide intra-articular para controle da dor BR112023001926A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063061395P 2020-08-05 2020-08-05
PCT/US2021/044619 WO2022031898A1 (en) 2020-08-05 2021-08-05 Pharmaceutical composition of intra-articular corticosteroid for pain control

Publications (1)

Publication Number Publication Date
BR112023001926A2 true BR112023001926A2 (pt) 2023-03-07

Family

ID=77519828

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023001926A BR112023001926A2 (pt) 2020-08-05 2021-08-05 Composição farmacêutica de corticosteroide intra-articular para controle da dor

Country Status (13)

Country Link
US (1) US12514820B2 (https=)
EP (1) EP4192426A1 (https=)
JP (1) JP2023537474A (https=)
KR (1) KR20230048066A (https=)
CN (1) CN116348093A (https=)
AU (1) AU2021320774A1 (https=)
BR (1) BR112023001926A2 (https=)
CA (1) CA3187955A1 (https=)
CL (1) CL2023000315A1 (https=)
IL (1) IL300354A (https=)
MX (1) MX2023001410A (https=)
TW (1) TW202220668A (https=)
WO (1) WO2022031898A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2854769T1 (sl) * 2012-07-05 2023-09-29 Taiwan Liposome Company, Ltd. Postopki za zdravljenje artritisa
ES2985871T3 (es) * 2017-03-14 2024-11-07 Seikagaku Kogyo Co Ltd Composición para tratar artropatías y kit que incluye la misma
EP3849522A1 (en) * 2018-09-16 2021-07-21 TLC Biopharmaceuticals, Inc. Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain

Also Published As

Publication number Publication date
EP4192426A1 (en) 2023-06-14
TW202220668A (zh) 2022-06-01
KR20230048066A (ko) 2023-04-10
IL300354A (en) 2023-04-01
US20230285293A1 (en) 2023-09-14
JP2023537474A (ja) 2023-09-01
CN116348093A (zh) 2023-06-27
US12514820B2 (en) 2026-01-06
AU2021320774A1 (en) 2023-03-09
WO2022031898A1 (en) 2022-02-10
CA3187955A1 (en) 2022-02-10
CL2023000315A1 (es) 2023-09-22
MX2023001410A (es) 2023-03-06

Similar Documents

Publication Publication Date Title
BR112022009571A2 (pt) Uso de inibidor de fak na preparação de um fármaco para tratar tumores que têm mutação nras
ES2538835T3 (es) Tratamiento de lesiones de tejidos blandos utilizando el ácido hialurónico y la toxina botulínica
BRPI0707235B1 (pt) formulação de fentanil sublingual sem propelente, e, dispositivo de dose unitária para administração sublingual de uma formulação de fentanil sublingual
BR112015009504A2 (pt) inibidores de rock
BR112022024999A2 (pt) Inibidor tlr7 em combinação com prednisolona ou hidroxicloroquina para o tratamento do lúpus eritematoso cutâneo
BR112018011700A2 (pt) ?moduladores de canais de kv3 para tratar dor?
CA2541813C (en) Methods for treating acute and overuse sprain and strain using hyaluronic acid
BR112012030641A2 (pt) métodos e composições para terapia farmacêutica oral
BR112023016035A2 (pt) Métodos e composição farmacêutica para tratamento de doenças
Jain et al. Botox in dentistry: The healing side of A poison
BR112022025920A2 (pt) Tratamento de artrite reumatoide
BR112023001926A2 (pt) Composição farmacêutica de corticosteroide intra-articular para controle da dor
Soleimanpour et al. Novel treatment in refractory tic douloureux
MX2025000682A (es) Composicion farmaceutica de anticuerpo anti-cd20 y uso de la misma
BR112023023702A2 (pt) Métodos de tratamento da cistite intersticial/síndrome da dor na bexiga
Shen et al. The effects of an intraperitoneal single low dose of ketamine in attenuating the postoperative skin/muscle incision and retraction-induced pain related to the inhibition of N-methyl-D-aspartate receptors in the spinal cord
BR112023021049A2 (pt) Uso de adenina na fabricação de um medicamento para tratamento de úlcera diabética
BR112023000808A2 (pt) Lomitapida para uso em métodos para tratar hiperlipidemia e hipercolesterolemia em pacientes pediátricos
BR112013017829A2 (pt) método de tratamento de um paciente com sintomas de prostatite e/ou síndrome da dor pélvica e método de tratamento de um paciente com sintomas de prostatite crônicas/síndrome de dor pélvica crônica
BR112023024354A2 (pt) Método de tratamento de tremor essencial
BR112022026883A2 (pt) Tratamento de dor cirúrgica pós-operatória
BR112023026985A2 (pt) Medicamento para o tratamento e/ou prevenção do câncer, agente que aumenta a eficácia do medicamento em uma composição farmacêutica, agente para aumentar a eficácia do medicamento em uma composição farmacêutica e método para tratar e/ou prevenir o câncer
BR112022010493A2 (pt) Métodos para tratar sintomas comportamentais e psicológicos em pacientes com demência
KR20230173787A (ko) 내향성 발톱 치료 패치
RU2417091C2 (ru) Способ лечения артрозо-артритов

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]